NATIONAL TB 2012 INDICATOR ANALYSIS REPORT Presented by: Sandile Ginindza Lugogo Sun Hotel 05 th -7 th June 2013 Ministry of Health NTCP.

Slides:



Advertisements
Similar presentations
Improving diagnosis TB laboratory strengthening.
Advertisements

Overview of current case and treatment outcome definitions Malgosia Grzemska TB Operations and Coordination Stop TB Department Consultation Impact of WHO-endorsed.
Module 9 Part A: Monitoring and Evaluation *Image courtesy of: World Lung Foundation.
International Standards of Tuberculosis Care Implementation by Pulmonologists in Private Practice in Jakarta E. Burhan 1, M. A. Nawas 1, D. Kusumo Sutoyo.
Accelerating PMDT scale up in Ethiopia
Dr R.Reesaul Chest Physician Chest Clinic P. D`or Hospital
Monitoring and Evaluation Frameworks Kyiv, Ukraine May 23, 2006 MEASURE Evaluation.
Country Progress Report Philippines
Monitoring and Evaluation: Tuberculosis Control Programs
Monitoring and Evaluation: A Review of Terms. Goals To provide better treatment for people with tuberculosis in Country X To achieve a treatment success.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs Using the Compendium to Plan for Monitoring and Evaluation of NTPs.
Introduction to Monitoring and Evaluation for National TB Programs 20 September 2005.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Monitoring and Evaluation Frameworks   What is an M&E Framework?   Why do we use M&E Frameworks?   How do we develop M&E Frameworks? MEASURE Evaluation.
1 TB service and Health insurance Extending TB benefit package to help mitigate economic burden of TB patients, Cambodia contex TAG-NTP manager Meeting.
COUNTRY XEPERIENCE AND RESPONSE TO MDR AND XDR TUBERCULOSIS PRESENTED AT THE WHO TB/HIV PLANNING MEETING, ADDIS ABBABA, 11-12, NOVEMBER 2008 BY MS GUGU.
World Tuberculosis Day 2014 The TB situation in 2012: Findings from the joint TB surveillance and monitoring report by ECDC and the WHO Regional Office.
Health Information System “ Consumers’ perspective” Gunnar Bjune March 2013
Revised National Tuberculosis Control Programme (RNTCP)
Status of Revised National Tuberculosis Control Program (RNTCP) in India Dr Jitendra.
1 Global and Regional Tuberculosis (TB) update ACSM workshop, Amman, Jordan April 13-17, 2008 Dr. Sevil Huseynova.
Accelerating TB/HIV activities in Zambia Alwyn Mwinga 2007 HIV Implementers Meeting 20 June 2007.
Health Information System “ Consumers’ perspective” Gunnar Bjune March 2014
MDR-TB: a fight we cannot afford to lose! Alexander Golubkov, MD, MPH Senior TB Technical Advisor.
TB 101: TB Basics and Global Approaches. Objectives Review basic TB facts. Define common TB terms. Describe key global TB prevention and care strategies.
Challenge 4: Linking TB & HIV/AIDS Programs Kayt Erdahl, Project HOPE Rodrick Nalikungwi, Project HOPE Malawi December 18, 2008.
1 TB/HIV Project in the Philippines Yumiko Yanase.
DRUG-RESISTANT TB in SOUTH AFRICA: Issues & Response _ ______ _____ _ ______ _____ ___ __ __ __ __ __ _______ ___ ________ ___ _______ _________ __ _____.
Mongolia Progress Report Dr. D. Otgontsetseg, Head of recording and reporting unit, TB surveillance and research department, NCCD The ninth Technical Advisory.
Action Plan Good Health Situation of Population in Capital of Myanmar Yangon Division By DR MYA THIDA AYE.
Monitoring and Evaluation Module 12 – March 2010.
Tuberculosis Research of INA-RESPOND on Drug-resistant
Experience with Tb diagnostics and Scale up of services Botswana, Nigeria, and Tanzania Ernest Ekong, MD,MPH National Clinical Coordinator Harvard PEPFAR.
Japan Dr. Ismail M. Aboshama Zidan Surveillance Coordinator of NTP-Egypt Action Plan to Strengthen Laboratory Diagnostic.
Indicators for ACSM.
Update of the Global Plan to Stop TB TB/HIV Working Group Meeting Geneva, November 2009 Christian Lienhardt.
Monitoring Process of the National TB Control Program (NTP) in the Philippines Anna Marie Celina G. Garfin, MD Medical Specialist IV National Center for.
PMDT expansion is first of all expansion of DR-TB detection services Workshop on the development and implementation of supervision and patient support.
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
Recent Epidemiologic Situations of TB in Myanmar -Preliminary Review of Data from routine TB surveillance focusing on Case Finding- 9 May 2014, Nay Pyi.
Tuberculosis control in Suriname Situational analysis.
Name of LGU Accomplishment Report NTP Year-End Evaluation and Planning Workshop November 23-27, 2009.
Scale up TB/HIV activities in Asia Pacific 8-9Aug09 1 TB/HIV collaborative activities in Thailand Sriprapa Nateniyom, M.D. TB Bureau, Department of Disease.
Dr Ral Antic Chair Scientific Committee IUATLD-APR Australia Pre-Conference Workshop 1 National TB Control Program Summary & Remarks.
Global Fund Grant Proposal Round 11: Tuberculosis Nathan Furukawa Gabriella Boyle Rebekah Miner Paa Kobina Forson Xiaoxue Huang Hunter Pugh Gap Analysis.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
TB AND HIV: “THE STRATEGIC VISION FOR THE COUNTRY” Dr Lindiwe Mvusi 18 May 2012 MMPA Congress 2012.
World Tuberculosis Day 2016 Monitoring the implementation of the Framework Action Plan to Fight Tuberculosis in the European Union – Situation in 2014.
TB/ HIV CONTROL AND MANAGEMENT IN SOUTH AFRICA
Monitoring and Evaluation: A Review of Terms
Monitoring and Evaluation Frameworks
Addressing the challenges and successes of expediting TB treatment among PLHIV who are seriously ill: experience from Kenya Masini E & Olwande C National.
World Tuberculosis Day 2014
The burden of TB in the Western Pacific
Monitoring the implementation of the TB Action Plan for the WHO European Region, 2016–2020 EU/EEA situation in 2016 ECDC Tuberculosis Programme European.
Key issues in DOTS implementation
World Tuberculosis Day 2016
World Tuberculosis Day 2014
Dr. Joseph Bana-Koiri Dr. Gilbert Hiawalyer Papua New Guinea
Indian Scenario HIV Situation TB Situation
SURVEILLANCE AND EPIDEMIOLOGY OF TUBERCULOSIS IN FIJI
DOTS IMPACT TO TUBERCULOSIS IN LITHUANIA
Cheng shiming National TB Center in China May,3, 2004
monitoring & evaluation THD Unit, Stop TB department WHO Geneva
TB epidemiology in Bulgaria
TB SUREVEILLANCE MEETING: OBJECTIVES
Issues on the current information system
Surveillance, Monitoring and Evaluation Working Group
Monitoring and Evaluation: A Review of Terms
Presentation transcript:

NATIONAL TB 2012 INDICATOR ANALYSIS REPORT Presented by: Sandile Ginindza Lugogo Sun Hotel 05 th -7 th June 2013 Ministry of Health NTCP

TB Notifications Trends

Systematic TB Screening

TB Screening cont’d

TB Screening Cont’d

TB Notifications

Declining TB Burden

Trends in Distribution of TB cases by Sex

CHILDHOOD TB NOTIFICATIONS

Estimated number of deaths 490,000 (range: 470,000–510,000) 327,000 Estimated TB Notifications The Global Childhood TB Burden Estimated Incident TB cases 64,000 (range: 58,000–71,000)

Swaziland Childhood TB Situation

TB Screening cont’d

TB Screening Cont’d

Notification of Childhood TB Cases

TB/HIV Services Among Childhood TB Patients

MDR-TB Among Children

TB/HIV Services (All Forms)

Sputum Conversions…

Regional Conversions…2012 Sputum Conversion Region Overall HhohhoLubomboManziniShiselweni Converted New cases 73%57%59%69% 65% New SND 10% 21%24% 14% 17% New Failure to convert cases 9% 16% 10% 12% Died New cases6% 4% 5% Converted Retreatment Cases 54%34%50%56% 49% SND retreatment cases 12% 28%19%20% Retreatment Failure to convert cases 22% 20% 5% 17% Died Retreatment cases10%8%11%5%9%

Treatment Outcomes

Treatment Success…

Unfavourable Treatment Outcomes TB Outcomes #%#%#%#%#% Died New SS % % % % 206 8% Defaulted New SS % 250 8% 245 7% 166 5% 130 5% Transferred out New SS % 81 3% 70 2% 65 2% 75 3% Treatment failures New SS % 236 7% 240 7% 259 8% 203 8% Died Retreatment cases % % % % % Defaulted Retreatment cases % 127 9% % 102 7% 81 7% Failure Retreatment cases 97 7% % 133 9% % % Transferred Out Retreatment % 53 4% 57 4% 77 5% 35 3%

ASSESSMENT OF PROGRESS TOWARDS 2014 STRATEGIC PLAN ASPIRATIONS TB CORE INDICATORS AS OUTLINED IN M&E PLAN

IMPACT INDICATORS Indicator NameTarget by 2014Actual by Dec 2012 Comment on likelihood of achievement Program Impact TB Incidence1365/ / Very likely however, given the declining notifications the relevancy of the incidence rate is weakened. TB Prevalence746/ / Less likely though the variance is within margin TB Mortality29/ / Less likely though the variance is within margin

OUTCOME INDICATORS Indicator NameTarget by 2014Actual by Dec 2012 Comment on likelihood of achievement Program Outcome TB Treatment Success82%73% likely to be achieved if current gains are sustained and strengthened TB Case Detection (All)100%53%Will not be met. TB Case Notification Rate 1149/ / Will not be met however, the notifications declined when least expected hence the variance

OUTPUT INDICATORS Retreatment TB cases12%11% New Pulmonary TB SND15%20% New Pulmonary TB SS+40%33% Sputum Conversion Rate (New)75%63% Sputum Conversion Rate (Retreatment) 60%50% Cure Rate of New TB cases60%48% Cure Rate of Re-treatments35%34% Treatment Completion rate22%25% Treatment Failure rate5%8% Default rate7%5% Smear Positivity rate40%37% Retreatment Failure rate (Chronic TB) 15%10%

OUTPUT INDICATORS % HCFs initiating TB Treatment 67/139 (48%)73/139 (53%) % Health Staff trained in TB 70%No reliable data TB Control is among Stated Priorities 10% increase for TB Budget Data still being validated Availability of TB Program Manual No target Manual available & Partly distributed Availability of TB Program Strategic Plan & Budget No targetYes

OUTPUT INDICATORS Diagnosis & Lab TB Microscopy coverage (Ratio)No target1/ TB Culture services coverage ratioNo target1/ % Laboratories performing regular EQA90%100% Private Public Mix % Private HCFs submitting TB Notifications15%11% % Patients detected in the private sector11%4% Drug Management Existence of Buffer Stock at Central & Peripheral levels No targetNo reliable data Accuracy of Stock Records for anti-TB drugs80%No reliable data % HCFs reporting no stock-out of anti-TB drugs 100%

OUTPUT INDICATORS TB/HIV % PLWHA Screened for TB100%No reliable Denominator % Registered TB patients who received HIV testing 90%92% HIV Ser0-prevalence among TB patients75%80% % registered TB/HIV Patients started on ART50%66% Supervision & Patient Support % of facilities receiving periodic supportive supervision from NTCP 80%22/73 (30%) % Registered TB Patients receiving direct observation of treatment (D.O.T.) 85%4025/7741 (52%) % MDR-TB Patients receiving DOT97%113/220 (51%) % Laboratory Confirmed MDR-TB cases33%220/2437 (9%) % Laboratory Confirmed MDR-TB cases enrolled on second line treatment 86%185/220 (84%)

Quick Reflections… WHERE TO FROM HERE…. - What policy directions & strategies are relevant?